Chinese | English

Search in the results

HFCAS OpenIR

Browse/Search Results:  1-10 of 24 Help

Selected(0)Clear Items/Page:    Sort:
Long-term exposure to copper induces mitochondria-mediated apoptosis in mouse hearts 期刊论文
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2022, 卷号: 234
Authors:  Pan, Ming;  Zi-Wei Cheng;  Chen-Guang Huang;  Zhu-Qing Ye;  Li-Jun Sun;  Chen, Hua;  Bei-Bei Fu;  Zhou, Kai;  Zhi-Rui Fang;  Zi-Jian Wang;  Qing-Zhong Xiao;  Xue-Sheng Liu;  Feng-Qin Zhu;  Gao, Shan
Favorite  |  View/Download：2/0  |  Submit date：2022/05/16
Copper  Cardiomyocytes  Mitochondria  Apoptosis  
Neutronics study of a subcritical system driven by external neutron source for Mo-99 production 期刊论文
FUSION ENGINEERING AND DESIGN, 2021, 卷号: 165
Authors:  Ren, Lei;  Li, Zi-Wei;  Han, Yun-Cheng;  Wang, Xiao-Yu;  Zhang, Jia-Chen
Favorite  |  View/Download：2/0  |  Submit date：2021/05/06
Medical radioisotope Mo-99  Neutronics  Sub-critical system  LEU solution  UO2SO4  
Osimertinib successfully combats EGFR-negative glioblastoma cells by inhibiting the MAPK pathway 期刊论文
ACTA PHARMACOLOGICA SINICA, 2020
Authors:  Chen, Cheng;  Cheng, Chuan-dong;  Wu, Hong;  Wang, Zuo-wei;  Wang, Li;  Jiang, Zong-ru;  Wang, Ao-li;  Hu, Chen;  Dong, Yong-fei;  Niu, Wan-xiang;  Qi, Shuang;  Qi, Zi-ping;  Liu, Jing;  Wang, Wen-chao;  Niu, Chao-shi;  Liu, Qing-song
View  |  Adobe PDF(3476Kb)  |  Favorite  |  View/Download：21/5  |  Submit date：2020/11/26
glioblastoma  osimertinib  temozolamide  MAPK-signaling pathway  MNK  eukaryotic translation initiation factor 4E  
Research on Lane-Change Strategy With Real-Time Obstacle Avoidance Function 期刊论文
IEEE ACCESS, 2020, 卷号: 8
Authors:  Wu, Qiong;  Liu, Wu-Dong;  Guo, Shi-Yong;  Cheng, Shuo;  Li, Shao-Jie;  Liang, Hua-Wei;  Liu, Zi-Jun
Favorite  |  View/Download：4/0  |  Submit date：2020/12/28
Lane change  obstacle avoidance  path planning  control mode matrix  
医用放射性同位素99Mo/99mTc生产现状和展望 期刊论文
原子核物理评论, 2019, 卷号: 036
Authors:  李紫微;  韩运成;  王晓彧;  张佳辰;  王永峰;  黄群英
Favorite  |  View/Download：1/0  |  Submit date：2020/11/25
医用放射性同位素  99Mo/99mTc  生产方式  分离纯化  
Discovery of 4-((N-(2-(dimethylamino)ethyl)acrylamido)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide (CHMFL-PDGFR-159) as a highly selective type II PDGFR alpha kinase inhibitor for PDGFR alpha driving chronic eosinophilic leukemia 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 150, 期号: 无, 页码: 366-384
Authors:  Wang, Qiang;  Liu, Feiyang;  Qi, Shuang;  Qi, Ziping;  Yan, Xiao-E.;  Wang, Beilei;  Wang, Aoli;  Wang, Wei;  Chen, Cheng;  Liu, Xiaochuan;  Jiang, Zongru;  Hu, Zhenquan;  Wang, Li;  Wang, Wenchao;  Ren, Tao;  Zhang, Shanchun;  Yun, Cai-Hong;  Liu, Qingsong;  Liu, Jing
View  |  Adobe PDF(5108Kb)  |  Favorite  |  View/Download：531/488  |  Submit date：2019/06/10
PDGFR kinase  Type II inhibitor  Kinase inhibitor  CEL  
Discovery of 1-(4-(4-Amino-3-(4-(2-morpholinoethoxy)-phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)phenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea (CHMFL-FLT3-213) as a Highly Potent Type II FLT3 Kinase Inhibitor Capable of Overcoming a Variety of FLT3 Kinase Mutants in FLT3-ITD Positive AML 期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 60, 期号: 20, 页码: 8407-8424
Authors:  Wang, Aoli;  Li, Xixiang;  Chen, Cheng;  Wu, Hong;  Qi, Ziping;  Hu, Chen;  Yu, Kailin;  Wu, Jiaxin;  Liu, Juan;  Liu, Xiaochuan;  Hu, Zhenquan;  Wang, Wei;  Wang, Wenliang;  Wang, Wenchao;  Wang, Li;  Wang, Beilei;  Liu, Qingwang;  Li, Lili;  Ge, Jian;  Ren, Tao;  Zhang, Shanchun;  Xia, Ruixiang;  Liu, Jing;  Liu, Qingsong
View  |  Adobe PDF(10028Kb)  |  Favorite  |  View/Download：30/15  |  Submit date：2019/06/17
Discovery of N-(5-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-4-methoxy-2-(4-methyl-1,4-diazepan-1-yl)phenyl)acrylamide (CHMFL-ALK/EGFR-050) as a potent ALK/EGFR dual kinase inhibitor capable of overcoming a variety of ALK/EGFR associated drug resistant mutants in NSCLC 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 139, 期号: 无, 页码: 674-697
Authors:  Chen, Yongfei;  Wu, Jiaxin;  Wang, Aoli;  Qi, Ziping;  Jiang, Taoshan;  Chen, Cheng;  Zou, Fengming;  Hu, Chen;  Wang, Wei;  Wu, Hong;  Hu, Zhenquan;  Wang, Wenchao;  Wang, Beilei;  Wang, Li;  Ren, Tao;  Zhang, Shanchun;  Liu, Qingsong;  Liu, Jing
View  |  Adobe PDF(12656Kb)  |  Favorite  |  View/Download：21160/11439  |  Submit date：2018/08/17
Egfr  Alk  Dual Kinase Inhibitor  Non-small Cell Lung Cancer  
Discovery of (R)-1-(3-(4-Amino-3-(3-chloro-4-(pyridin-2-ylmethoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (CHMFL-EGFR-202) as a Novel Irreversible EGFR Mutant Kinase Inhibitor with a Distinct Binding Mode 期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 60, 期号: 7, 页码: 2944-2962
Authors:  Wang, Aoli;  Li, Xixiang;  Wu, Hong;  Zou, Fengming;  Yan, Xiao-E;  Chen, Cheng;  Hu, Chen;  Yu, Kailin;  Wang, Wenchao;  Zhao, Peng;  Wu, Jiaxin;  Qi, Ziping;  Wang, Wei;  Wang, Beilei;  Wang, Li;  Ren, Tao;  Zhang, Shanchun;  Yun, Cai-Hong;  Liu, Jing;  Liu, Qingsong
Favorite  |  View/Download：11/0  |  Submit date：2018/07/26
Discovery of (R)-1-(3-(4-Amino-3-(3-chloro-4-(pyridin-2-ylmethoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (CHMFL-EGFR-202) as a Novel Irreversible EGFR Mutant Kinase Inhibitor with a Distinct Binding Mode 期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 60, 期号: 7, 页码: 2944-2962
Authors:  Wang, Aoli;  Li, Xixiang;  Wu, Hong;  Zou, Fengming;  Yan, Xiao-E;  Chen, Cheng;  Hu, Chen;  Yu, Kailin;  Wang, Wenchao;  Zhao, Peng;  Wu, Jiaxin;  Qi, Ziping;  Wang, Wei;  Wang, Beilei;  Wang, Li;  Ren, Tao;  Zhang, Shanchun;  Yun, Cai-Hong;  Liu, Jing;  Liu, Qingsong
Favorite  |  View/Download：17/0  |  Submit date：2018/07/26